Advertisement

Topics

Europe steps up action against vaccine hesitancy as measles outbreaks continue

09:03 EDT 16 Oct 2017 | British Medical Journal

The goal of eliminating measles from Europe was dealt a blow last week after new data showed how outbreaks continue to sweep the continent.Nearly 19 000 cases of measles were reported in the European...

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: Europe steps up action against vaccine hesitancy as measles outbreaks continue

NEXT ARTICLE

More From BioPortfolio on "Europe steps up action against vaccine hesitancy as measles outbreaks continue"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Measles
Measles (morbilli, rubeola) is a highly infectious viral illness that can be very unpleasant and can sometimes lead to serious complications.  The initial symptoms of measles develop around 10 days after initial infection: a high temperature (...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.